Literature DB >> 22035430

MDHAQ/RAPID3 scores: quantitative patient history data in a standardized "scientific" format for optimal assessment of patient status and quality of care in rheumatic diseases.

Theodore Pincus1, Isabel Castrejón.   

Abstract

Quantitative measurement according to a laboratory test such as hemoglobin A1c or creatinine provides a "gold standard" for care of every individual with a specific diagnosis. By contrast, no single "gold standard" quantitative measure is available in rheumatic diseases. Laboratory tests are limited, and clinical decisions are based more on patient history and physical examination than laboratory tests. A quantitative patient history is provided by a self-report questionnaire as standardized, "scientific" data to compare from one visit to the next. Patient questionnaires for usual clinical care emphasize feasibility, acceptability to patients and physicians, and clinical utility, which are not considered in research questionnaires. Development of a multidimensional health assessment questionnaire (MDHAQ) over 27 years is seen as a continuous quality improvement (CQI) rather than research activity, to account for all rather than a few selected patients for a research study. Both the traditional HAQ and MDHAQ are 2-page questionnaires, easily completed by patients in 5 to 10 minutes, although scoring a HAQ disability index (HAQ-DI) requires 42 seconds, compared to 5 seconds for an MDHAQ/RAPID3. The MDHAQ includes, within 2 pages: complex activities, psychological queries, visual analog scales (VAS) as 21 numbered circles rather than 10-cm lines, a fatigue VAS, RADAI (rheumatoid arthritis disease activity index) self-report joint count, traditional "medical" review of systems and recent medical history, and demographic data, as well as a data management system that incorporates medication data and laboratory tests, reports for physicians and patients, and flow sheets to compare a current visit with a previous visit.

Entities:  

Mesh:

Year:  2011        PMID: 22035430

Source DB:  PubMed          Journal:  Bull NYU Hosp Jt Dis        ISSN: 1936-9719


  6 in total

1.  Rheumatoid arthritis quality measures and radiographic progression.

Authors:  Sonali P Desai; Chih-Chin Liu; Heather Tory; Tabatha Norton; Michelle Frits; Siri Lillegraven; Michael Weinblatt; Jonathan Coblyn; Jinoos Yazdany; Nancy Shadick; Daniel H Solomon
Journal:  Semin Arthritis Rheum       Date:  2014-01-25       Impact factor: 5.532

2.  Patient-reported outcomes in ANCA-associated vasculitis. A comparison between Birmingham Vasculitis Activity Score and routine assessment of patient index data 3.

Authors:  Narender Annapureddy; Osama Elsallabi; Joshua Baker; Antoine G Sreih
Journal:  Clin Rheumatol       Date:  2015-03-31       Impact factor: 2.980

3.  Development of the American College of Rheumatology's Rheumatoid Arthritis Electronic Clinical Quality Measures.

Authors:  Jinoos Yazdany; Mark Robbins; Gabriela Schmajuk; Sonali Desai; Diane Lacaille; Tuhina Neogi; Jasvinder A Singh; Mark Genovese; Rachel Myslinski; Natalie Fisk; Melissa Francisco; Eric Newman
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-11       Impact factor: 4.794

4.  Specific management of post-chikungunya rheumatic disorders: a retrospective study of 159 cases in Reunion Island from 2006-2012.

Authors:  Emilie Javelle; Anne Ribera; Isabelle Degasne; Bernard-Alex Gaüzère; Catherine Marimoutou; Fabrice Simon
Journal:  PLoS Negl Trop Dis       Date:  2015-03-11

5.  Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care.

Authors:  Sung-Hoon Park; Jung-Yoon Choe; Seong-Kyu Kim; Hwajeong Lee; Isabel Castrejón; Theodore Pincus
Journal:  J Clin Rheumatol       Date:  2015-09       Impact factor: 3.517

6.  Pragmatic assessment of exercise in routine care using an MDHAQ: associations with changes in RAPID3 and other clinical variables.

Authors:  Isabel Castrejón; Yusuf Yazici; Selda Celik; Theodore Pincus
Journal:  Arthritis Res Ther       Date:  2016-09-06       Impact factor: 5.156

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.